<VariationArchive VariationID="1676617" VariationName="NM_000094.4(COL7A1):c.329_332dup (p.Ser111_Tyr112insTer)" VariationType="Duplication" Accession="VCV001676617" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-30" DateCreated="2022-08-29" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1668104" VariationID="1676617">
      <GeneList>
        <Gene Symbol="COL7A1" FullName="collagen type VII alpha 1 chain" GeneID="1294" HGNC_ID="HGNC:2214" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>3p21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="48564073" stop="48595329" display_start="48564073" display_stop="48595329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="48601505" stop="48632592" display_start="48601505" display_stop="48632592" Strand="-" />
          </Location>
          <OMIM>120120</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000094.4(COL7A1):c.329_332dup (p.Ser111_Tyr112insTer)</Name>
      <VariantType>Duplication</VariantType>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.48631064_48631067dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.48631064_48631067dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.48593631_48593634dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.48593631_48593634dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007065.1" sequenceAccession="NG_007065" sequenceVersion="1" change="g.6619_6622dup">
            <Expression>NG_007065.1:g.6619_6622dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000094.4" sequenceAccession="NM_000094" sequenceVersion="4" change="c.329_332dup" MANESelect="true">
            <Expression>NM_000094.4:c.329_332dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000085.1" sequenceAccession="NP_000085" sequenceVersion="1" change="p.Ser111_Tyr112insTer">
            <Expression>NP_000085.1:p.Ser111_Tyr112insTer</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_286" sequenceAccession="LRG_286">
            <Expression>LRG_286:g.6619_6622dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_286t1" sequenceAccession="LRG_286t1">
            <Expression>LRG_286t1:c.329_332dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1256976418" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000094.4(COL7A1):c.329_332dup (p.Ser111_Tyr112insTer) AND Recessive dystrophic epidermolysis bullosa" Accession="RCV002277053" Version="1">
        <ClassifiedConditionList TraitSetID="5728">
          <ClassifiedCondition DB="MedGen" ID="C0079474">Recessive dystrophic epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000094.4(COL7A1):c.329_332dup (p.Ser111_Tyr112insTer) AND not provided" Accession="RCV003728045" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-08-29" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16971478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35979658</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5728" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1160" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hallopeau-Siemens Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0024" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0036" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0037" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0038" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120120.0025" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Recessive dystrophic epidermolysis bullosa</ElementValue>
                <XRef ID="Recessive+dystrophic+epidermolysis+bullosa/9208" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009179" DB="MONDO" />
                <XRef ID="48528004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">severe generalized recessive dystrophic epidermolysis bullosa</ElementValue>
                <Citation Type="general">
                  <ID Source="PubMed">18374450</ID>
                </Citation>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Distrophica Autosomal Recessive (RDEB)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EBR1</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RDEB</ElementValue>
                <XRef Type="MIM" ID="226600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%. In contrast, the blistering in the less severe forms of RDEB may be localized to hands, feet, knees, and elbows with or without involvement of flexural areas and the trunk, and without the mutilating scarring seen in severe generalized RDEB. In DDEB, blistering is often mild and limited to hands, feet, knees, and elbows, but nonetheless heals with scarring. Dystrophic nails, especially toenails, are common and may be the only manifestation of DDEB.</Attribute>
                <XRef ID="NBK1304" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6308" />
                <XRef ID="6308" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="79408" DB="Orphanet" />
              <XRef ID="79409" DB="Orphanet" />
              <XRef ID="C0079474" DB="MedGen" />
              <XRef ID="MONDO:0009179" DB="MONDO" />
              <XRef Type="MIM" ID="226600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4889061" SubmissionDate="2022-04-12" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="NM_000094.3:c.329_332dup|OMIM:226600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002499327" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Center for Research in Genodermatoses and Epidermolysis Bullosa, University of Buenos Aires" OrgID="508489" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">35979658</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Sanger Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000094.3:c.329_332dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226600" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">35979658</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11321124</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8322973" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="9522993|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004535004" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16971478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35979658</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr112*) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive dystrophic epidermolysis bullosa (PMID: 35979658). ClinVar contains an entry for this variant (Variation ID: 1676617). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL7A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.48631063_48631064insCTAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4889061" TraitType="Disease" MappingType="XRef" MappingValue="226600" MappingRef="OMIM">
        <MedGen CUI="C0079474" Name="Recessive dystrophic epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8322973" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

